CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.89 CNY | +1.45% |
|
-2.83% | -5.62% |
| Apr. 29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.44B 337M | Sales 2023 | 2.11B 292M | Capitalization | 32.01B 4.42B |
|---|---|---|---|---|---|
| Net income 2022 | 553M 76.42M | Net income 2023 | 367M 50.72M | EV / Sales 2022 | 12.5 x |
| Net cash position 2022 | 5.17B 714M | Net cash position 2023 | 3.61B 500M | EV / Sales 2023 | 13.4 x |
| P/E ratio 2022 |
64.5
x | P/E ratio 2023 |
87.3
x | Employees | 1,803 |
| Yield 2022 |
0.29% | Yield 2023 |
0.35% | Free-Float | 33.14% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.45% | ||
| 1 week | -2.83% | ||
| Current month | +1.15% | ||
| 1 month | +29.34% | ||
| 3 months | +8.69% | ||
| 6 months | +0.33% | ||
| Current year | -5.62% |
1 week
50.32
53.45
1 month
39.7055.87
Current year
37.5055.87
1 year
37.5067.00
3 years
37.50137.14
5 years
37.50141.43
10 years
37.50141.43
| Managers | Title | Age | Since |
|---|---|---|---|
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
Wen Ying Yang
DFI | Director of Finance/CFO | - | - |
Chen Yang
COO | Chief Operating Officer | 40 | 19-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Keller
BRD | Director/Board Member | 75 | 19-08-17 |
Joachim Rudolf
BRD | Director/Board Member | 63 | 19-08-17 |
Xiu Cai Liu
CHM | Chairman | 67 | 19-08-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -12.16% | - | |
| 0.81% | 45 M€ | -12.92% | - | |
| 0.81% | 45 M€ | -13.77% | - | |
| 0.81% | 38 M€ | -11.51% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 51.89 | +1.45% | 2,191,951 |
| 24-05-17 | 51.15 | -1.25% | 1,896,239 |
| 24-05-16 | 51.8 | -2.96% | 3,553,463 |
| 24-05-15 | 53.38 | +1.33% | 2,307,290 |
| 24-05-14 | 52.68 | -1.35% | 2,891,916 |
End-of-day quote Shanghai S.E., May 19, 2024
More quotes
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.62% | 4.17B | |
| +14.70% | 1.84B | |
| -10.14% | 642M | |
| -12.74% | 455M | |
| -81.65% | 216M | |
| -11.25% | 114M | |
| -10.14% | 55.23M |
- Stock Market
- Equities
- 688065 Stock
